Rezum water vapour therapy: promising early outcomes from the first UK series
- PMID: 32777175
- DOI: 10.1111/bju.15203
Rezum water vapour therapy: promising early outcomes from the first UK series
References
-
- Dixon CM, Rijo Cedano E, Mynderse LA, Larson TR. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezum((R)) system: evaluation of acute ablative capabilities in the human prostate. Res Rep Urol 2015; 7: 13-8
-
- McVary KT, Rogers T, Roehrborn CG. Rezum water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology 2019; 126: 171-9
-
- McVary KT, Gange SN, Gittelman MC et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2016; 195: 1529-38
-
- Lin YH, Hou CP, Chen TH et al. Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction. BMC Geriatr 2018; 18: 15. DOI: 10.1186/s12877-018-0709-3
-
- Sonksen J, Barber NJ, Speakman MJ et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 2015; 68: 643-52
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical